Development and pan-cancer validation of an epigenetics-based random survival forest model for prognosis prediction and drug response in OS
BackgroundOsteosarcoma (OS) exhibits significant epigenetic heterogeneity, yet its systematic characterization and clinical implications remain largely unexplored.MethodsWe analyzed single-cell transcriptomes of five primary OS samples, identifying cell type-specific epigenetic features and their ev...
Saved in:
Main Authors: | Chaoyi Yin, Kede Chi, Zhiqing Chen, Shabin Zhuang, Yongsheng Ye, Binshan Zhang, Cailiang Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1529525/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
by: Binbin Liu, et al.
Published: (2025-01-01) -
The homeobox family gene signature predicts the prognosis of osteosarcoma and correlates with immune invasion
by: Wenda Liu, et al.
Published: (2025-01-01) -
OSTEOSARCOMA HAS NOT BECOME ATTENTION TO SOCIETY PROFILE OF OSTEOSARCOMA PATIENTS AT DR. SOETOMO GENERAL HOSPITAL SURABAYA "A RETROSPECTIVE STUDY”
by: Ferdiansyah Mahyudin, et al.
Published: (2019-12-01) -
A generative deep neural network for pan-digestive tract cancer survival analysis
by: Lekai Xu, et al.
Published: (2025-01-01) -
Determinants of Survival in Cancer Rectum: Our Experience at a Tertiary Care Center
by: Rashmi Singh, et al.
Published: (2024-12-01)